KRT88P and hepatitis A virus infection: The prevalence of viral hepatitis markers was assessed using serology and molecular methods.<h4>Results</h4>The prevalence rates of hepatitis markers among patients were as follows: anti-HAV, 15.2%; anti-HBs, 11.9%; anti-HBc/anti-HBs, 2.6%; anti-HCV, 4.0%; and anti-HEV, 14.6%.